PrEP Patient Information Sheet
PrEP Patient Information Sheet Read More »
PrEP
PrEP Use Up 500 Percent In Just Three Years
The Centers for Disease Control and Prevention announced that PrEP among at-risk men increased 500 percent between 2014 to 2017. And those numbers are expected to rise following Gilead Sciences’ new commitment to donate up to 2.4 million bottles of Truvada to the CDC by 2030 (which amounts to 200,000 per year). The study is
PrEP Use Up 500 Percent In Just Three Years Read More »
Drugmaker Gilead Is Making HIV Prevention Meds More Accessible
Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled
Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »
Education key to HIV awareness among youth
There is a generation gap when it comes to knowing and understanding HIV prevention. Young gay and bisexual men and other men who have sex with men (YGBM) in BC are less likely to be aware of some HIV prevention and treatment options compared to older men, according to a recently published BC-CfE study.
Education key to HIV awareness among youth Read More »
They Found a Better Way to Get Latinx Miami on PrEP
When the United Nations Commission on Human Rights declared last year that Venezuela was in “a downward spiral with no end in sight,” Marco Torrealba knew exactly what that meant. A former corporate journalist, Torrealba fled Venezuela in 2015 leaving behind his family, friends, and career. “I grew up in a very poor area in
They Found a Better Way to Get Latinx Miami on PrEP Read More »
Study confirms no transmissions with undetectable HIV
The largest treatment-as-prevention study for gay and bisexual men confirms that people on antiretroviral therapy with undetectable viral load do not transmit HIV. Results from the PARTNER2 study, which enrolled nearly 1,000 mixed-status gay male couples in 14 European countries, saw no genetically linked HIV transmissions when the positive partner was on effective treatment. “PARTNER2
Study confirms no transmissions with undetectable HIV Read More »
One year of preventing new HIV infections throughout B.C.
Thousands of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on Jan. 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see
One year of preventing new HIV infections throughout B.C. Read More »
One year of preventing new HIV infections throughout B.C.
THOUSANDS of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on January 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see
One year of preventing new HIV infections throughout B.C. Read More »
Testing, treatment and harm reduction
ANKORS opened an office in Cranbrook in September of 1999. ANKORS is an acronym for “AIDS Network Resource and Support Services.” The Vision: Individual and community wellness for all. The Mission: ANKORS’ mission is to respond to the evolving needs of those living with and affected by HIV/AIDS, Hepatitis C and other blood borne pathogens:
Testing, treatment and harm reduction Read More »